Guidance for industry : court decisions, ANDA approvals, and 180-day exclusivity under the Hatch-Waxman amendments to the Federal Food, Drug, and Cosmetic Act.

Bibliographic Details
Corporate Author:	Center for Drug Evaluation and Research (U.S.)
Format:	Government Document eBook
Language:	English
Published:	Rockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, [2000]
Subjects:	United States. > Federal Food, Drug, and Cosmetic Act. Drug approval > United States. Patent infringement > Government policy > United States.
Online Access:	https://purl.fdlp.gov/GPO/LPS117068

Available Online